chloroquine has been researched along with warfarin in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (27.59) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (24.14) | 29.6817 |
| 2010's | 11 (37.93) | 24.3611 |
| 2020's | 3 (10.34) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Chibale, K; Egan, TJ; Hunter, R; Joshi, MC; Ndove, J; Nsumiwa, S; Okombo, J; Taylor, D; Wiesner, L | 1 |
| Bia, FJ; Divo, AA; Patton, CL; Sartorelli, AC | 1 |
| Cepelák, V; Grimová, J; Nĕmecek, O; Roubal, Z | 1 |
| Holmes, J; Sapeika, N; Zwarenstein, H | 2 |
| Barg, TsM | 1 |
| Post, D | 1 |
| Chai, HB; Cordell, GA; Lee, KH; Pezzuto, JM; Tamez, PA; Tin-Wa, M; Win, KK | 1 |
| EL-MOFTY, AM | 1 |
| Caldas, CA; de Carvalho, JF | 1 |
| Abegaz, B; Bezabih, M; Hayeshi, R; Mangoyi, R; Mukanganyama, S; Ngadjui, B; Ngandeu, F; Rasoanaivo, P; Razafimahefa, S | 1 |
| Ansari, ZA; Chakrabarti, P; Chakraborty, S; Dey, S; Joshi, P; Shanker, V; Singh, SP | 1 |
| Kang, J; Li, X; Mao, X; Tian, Y; Tuohetaerbaike, B; Zhang, NN; Zhang, Y | 1 |
| Aisker, G; Dong, H; Halemahebai, G; Tian, L; Zhang, Y | 1 |
| Carrico-Moniz, D; Kusaka, E; Wang, Y; Webb, A; Zhang, J; Zhou, R | 1 |
2 review(s) available for chloroquine and warfarin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Eye complications during use of various medicinal substances with general effects (review of the literature)].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Allopurinol; Anti-Bacterial Agents; Antimalarials; Cardiac Glycosides; Cataract; Child; Chloroquine; Chlorpromazine; Epinephrine; Ethambutol; Ethchlorvynol; Eye Diseases; Female; Humans; Miotics; Nalidixic Acid; Phosphates; Pilocarpine; Quinolines; Retinal Degeneration; Warfarin | 1969 |
27 other study(ies) available for chloroquine and warfarin
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
4-Aminoquinoline Antimalarials Containing a Benzylmethylpyridylmethylamine Group Are Active against Drug Resistant Plasmodium falciparum and Exhibit Oral Activity in Mice.
Topics: Administration, Oral; Aminopyridines; Aminoquinolines; Animals; Antimalarials; Cell Membrane Permeability; Chloroquine; CHO Cells; Cricetulus; Drug Evaluation, Preclinical; Drug Resistance, Microbial; ERG1 Potassium Channel; Hemeproteins; Humans; Malaria; Male; Mice, Inbred BALB C; Plasmodium berghei; Plasmodium falciparum; Solubility; Structure-Activity Relationship | 2017 |
Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro.
Topics: Aminocoumarins; Animals; Anti-Infective Agents; Chloroquine; Ciprofloxacin; Coumarins; Drug Interactions; Drug Resistance; Enoxacin; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Novobiocin; Ofloxacin; Oxolinic Acid; Pefloxacin; Plasmodium falciparum; Tetracycline; Topoisomerase II Inhibitors | 1988 |
Effects of nonsteroid anti-inflammatory agents and some dicoumarol derivatives on platelet aggregation, fibrinolysis and stabilization of cell membrane in vitro.
Topics: Anti-Inflammatory Agents; Aspirin; Blood Platelets; Cell Membrane; Chloroquine; Coumarins; Depression, Chemical; Dicumarol; Erythrocytes; Fibrinolysis; Flufenamic Acid; Hemolysis; Humans; Hypotonic Solutions; In Vitro Techniques; Indomethacin; Inflammation; Mefenamic Acid; Oxyphenbutazone; Phenylbutazone; Phenylpropionates; Platelet Adhesiveness; Pyrazoles; Receptors, Drug; Structure-Activity Relationship | 1972 |
Effect of quinoline, phthalazine and coumarin derivatives on the absorbance of NADPH.
Topics: Chloroquine; Coumarins; Heterocyclic Compounds; Hydralazine; Indophenol; NADP; Novobiocin; Quinacrine; Quinidine; Quinine; Quinolines; Spectrophotometry; Warfarin | 1974 |
Lysosomes--a pipe-dream come true.
Topics: Chloroquine; Coumarins; Glycosaminoglycans; Lipids; Liver; Lysosomes | 1968 |
Inhibitory effect of some quinoline, phthalazine, and coumarin derivatives on glucose-6-phosphate dehydrogenase in vitro.
Topics: Binding, Competitive; Chloroquine; Coumarins; Glucosephosphate Dehydrogenase; Heterocyclic Compounds; Hydralazine; Isoniazid; Novobiocin; Phenazines; Phenelzine; Phenylhydrazines; Probenecid; Pyridines; Quinacrine; Quinidine; Quinine; Quinolines; Sulfanilamides; Warfarin; Yeasts | 1973 |
[Documentation in the toxicological laboratory. Practical identification of substances by means of punched feature cards].
Topics: Child; Chloroquine; Chromatography, Thin Layer; Coumarins; Forensic Medicine; Humans; Indicators and Reagents; Pharmaceutical Preparations; Phenacetin; Punched-Card Systems; Spectrum Analysis; Ultraviolet Rays | 1969 |
Biologically active alkylated coumarins from Kayea assamica.
Topics: Alkylation; Animals; Antimalarials; Antineoplastic Agents, Phytogenic; Chloroquine; Clusiaceae; Coumarins; Drug Screening Assays, Antitumor; Humans; KB Cells; Magnetic Resonance Spectroscopy; Molecular Conformation; Molecular Structure; Myanmar; Plant Bark; Plants, Medicinal; Plasmodium falciparum; Tumor Cells, Cultured | 2003 |
THE TREATMENT OF VITILIGO WITH A COMBINATION OF PSORALENS AND QUINOLINES.
Topics: Amodiaquine; Chloroquine; Copper; Coumarins; Dermatitis, Phototoxic; Furocoumarins; Humans; Iron; Photosensitivity Disorders; Quinolines; Sunlight; Toxicology; Ultraviolet Rays; Vitiligo | 1964 |
Primary antiphospholipid syndrome with and without Sneddon's syndrome.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Autoantibodies; Chloroquine; Female; Glucocorticoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prevalence; Sneddon Syndrome; Treatment Outcome; Venous Thrombosis; Warfarin | 2011 |
Glutathione transferase from Plasmodium falciparum--interaction with malagashanine and selected plant natural products.
Topics: Alkaloids; Biological Products; Chloroquine; Coumarins; Curcumin; Dinitrochlorobenzene; Drug Discovery; Drug Resistance; Ellagic Acid; Enzyme Inhibitors; Glutathione; Glutathione Transferase; Kinetics; Malaria, Falciparum; Plants, Medicinal; Plasmodium falciparum; Protozoan Proteins; Recombinant Proteins; Sesquiterpenes, Germacrane | 2010 |
Binding of chloroquine-conjugated gold nanoparticles with bovine serum albumin.
Topics: Animals; Antimalarials; Binding Sites; Borohydrides; Cattle; Chloroquine; Fatty Acids; Gold; Microscopy, Electron, Transmission; Models, Molecular; Nanoparticles; Particle Size; Protein Binding; Protein Structure, Tertiary; Serum Albumin, Bovine; Spectroscopy, Fourier Transform Infrared; Sulfhydryl Compounds; Thermodynamics; Tryptophan; Warfarin | 2011 |
Pancreas protective effects of Urolithin A on type 2 diabetic mice induced by high fat and streptozotocin via regulating autophagy and AKT/mTOR signaling pathway.
Topics: Animals; Autophagy; Blood Glucose; Chloroquine; Coumarins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Male; Mice; Mice, Inbred C57BL; Pancreas; Proto-Oncogene Proteins c-akt; Signal Transduction; Streptozocin; TOR Serine-Threonine Kinases | 2020 |
Urolithin A, a pomegranate metabolite, protects pancreatic β cells from apoptosis by activating autophagy.
Topics: Animals; Apoptosis; Autophagy; Cell Line; Cell Survival; Chloroquine; Coumarins; Diabetes Mellitus, Experimental; Glucose; Insulin-Secreting Cells; Lipids; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Pomegranate; Protective Agents | 2021 |
Isoprenylated Coumarin Exhibits Anti-proliferative Effects in Pancreatic Cancer Cells Under Nutrient Starvation by Inhibiting Autophagy.
Topics: Adenocarcinoma; Autophagy; Cell Line, Tumor; Chloroquine; Coumarins; Glucose; Humans; Nutrients; Pancreatic Neoplasms | 2022 |